Basu, Sankha S.
Stopka, Sylwia A. http://orcid.org/0000-0003-3761-6899
Abdelmoula, Walid M. http://orcid.org/0000-0003-3117-7389
Randall, Elizabeth C.
Gimenez-Cassina Lopez, BegoƱa
Regan, Michael S.
Calligaris, David
Lu, Fake F. http://orcid.org/0000-0001-6281-7639
Norton, Isaiah
Mallory, Melissa A.
Santagata, Sandro http://orcid.org/0000-0002-7528-9668
Dillon, Deborah A.
Golshan, Mehra
Agar, Nathalie Y. R. http://orcid.org/0000-0003-3149-3146
Article History
Received: 6 April 2020
Accepted: 26 July 2021
First Online: 9 September 2021
Competing interests
: In compliance with Harvard Medical School and Partners Healthcare guidelines on potential conflict of interest, we disclose that N.Y.R.A. is a consultant/advisory board member for BayesianDx and InviCRO. D.A.D. is a consultant for Novartis and on the Advisory Board for Oncology Analytics, Inc. S.S. is a consultant for RareCyte Inc. The remaining authors declare no competing interests.